Iopize

Latanoprost, the active ingredient in Iopize, is a prostaglandin analog presented as an ophthalmic solution for ocular use. It treats open-angle glaucoma and ocular hypertension in adults.

GNH USA supplies Iopize as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost is used in the management of ocular conditions that require reduction of intraocular pressure.

Open-angle glaucoma: lowers intraocular pressure to prevent optic nerve damage. Ocular hypertension: reduces elevated eye pressure to lower risk of developing glaucoma. Secondary open-angle glaucoma: helps control pressure when other therapies are insufficient.

Common Side Effects: - Ocular hyperemia (eye redness) - Increased eyelash length and thickness - Iris color darkening - Eye irritation or foreign body sensation - Blurred vision - Mild eye pain

Serious or Rare Side Effects: - Severe allergic reaction (e.g., angioedema) - Uveitis or iritis - Corneal edema or macular edema - Paradoxical increase in intraocular pressure - Infectious keratitis

Precautions should be observed when using Iopize.

Pregnancy: safety not established; avoid unless benefit outweighs risk. Breastfeeding: unknown; consider potential risks. Contraindications: active ocular inflammation or infection. Monitoring: intraocular pressure should be measured after initiation. Contact lens use: avoid wearing lenses for at least 15 minutes after instillation. Store at room temperature: keep in original container, protect from light and moisture, and do not freeze.

Iopize may interact with other ocular or systemic agents.

Major Interactions (Avoid): - Nonsteroidal anti‑inflammatory eye drops: may reduce efficacy. - Systemic prostaglandin inhibitors: may antagonize effect. - Concurrent prostaglandin analogs: additive pressure lowering may cause excessive reduction.

Moderate Interactions (Monitor Closely): - Beta‑blocker eye drops: additive intraocular pressure reduction. - Carbonic anhydrase inhibitor eye drops: additive effect on pressure. - Anticholinergic agents: may affect ocular surface tolerance.